CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published ahead of print on October 15, 2008
Clinical Journal of the American Society of Nephrology
© 2008 American Society of Nephrology
doi: 10.2215/CJN.01310308
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
CJN.01310308v1
3/6/1829    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evenepoel, P.
Right arrow Articles by Vanrenterghem, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evenepoel, P.
Right arrow Articles by Vanrenterghem, Y.

Received March 19, 2008
Accepted on July 17, 2008

ORIGINAL ARTICLES

Recovery of Hyperphosphatoninism and Renal Phosphorus Wasting One Year after Successful Renal Transplantation

Pieter Evenepoel 1, Bjorn K.I. Meijers , Hylke de Jonge , Maarten Naesens , Bert Bammens , Kathleen Claes , Dirk Kuypers , and Yves Vanrenterghem

Department of Medicine, Division of Nephrology, University Hospital Leuven, B-3000 Leuven, Belgium


1 To whom correspondence should be addressed. E-mail: Pieter.Evenepoel{at}uz.kuleuven.ac.be.


   Abstract

Background and objectives: In the first months after successful kidney transplantation, hypophosphatemia and renal phosphorus wasting are common and related to inappropriately high parathyroid hormone (PTH) and fibroblast growth factor-23 (FGF-23) levels. Little is known about the long-term natural history of renal phosphorus homeostasis in renal transplant recipients.

Design, setting, participants: We prospectively followed parameters of mineral metabolism (including full-length PTH and FGF-23) in 50 renal transplant recipients at the time of transplantation (Tx), at month 3 (M3) and at month 12 (M12). Transplant recipients were (1:1) matched for estimated GFR with chronic kidney disease (CKD) patients.

Results: FGF-23 levels (Tx: 2816 [641 to 10665] versus M3: 73 [43 to 111] versus M12: 56 [34 to 78] ng/L, median [interquartile range]) and fractional phosphorus excretion (FEphos; M3: 45 ± 19% versus M12: 37 ± 13%) significantly declined over time after renal transplantation. Levels 1 yr after transplantation were similar to those in CKD patients (FGF-23: 47 [34 to 77] ng/L; FEphos 35 ± 16%). Calcium (9.1 ± 0.5 versus 8.9 ± 0.3 mg/dl) and PTH (27.2 [17.0 to 46.0] versus 17.5 [11.7 to 24.4] ng/L) levels were significantly higher, whereas phosphorus (3.0 ± 0.6 versus 3.3 ± 0.6 mg/dl) levels were significantly lower 1 yr after renal transplantation as compared with CKD patients.

Conclusions: Data indicate that hyperphosphatoninism and renal phosphorus wasting regress by 1 yr after successful renal transplantation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American Society of Nephrology.